Caroline Bouter
Overview
Explore the profile of Caroline Bouter including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
343
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ott F, Sichler M, Bouter C, Enayati M, Wiltfang J, Bayer T, et al.
J Alzheimers Dis Rep
. 2025 Mar;
9:25424823241306770.
PMID: 40034517
Background: Alzheimer's disease (AD) is a neurodegenerative disorder characterized by cognitive decline and behavior impairments. Despite recent approvals of anti-amyloid antibodies, there remains a need for disease modifying and easily...
2.
Breitling B, Bartels C, Lange C, Bouter C, Falk H, Wiltfang J, et al.
Neuropsychobiology
. 2024 Dec;
83(5-6):214-225.
PMID: 39622206
Introduction: Diagnosis of frontotemporal dementia (FTD) remains difficult even in the presence of core clinical and imaging features. Furthermore, disease-modifying treatments are lacking. Case Presentation: Here, we report a case...
3.
Hansen N, Rentzsch K, Hirschel S, Wiltfang J, Schott B, Bartels C, et al.
Front Dement
. 2024 Jul;
2:1227823.
PMID: 39081998
Background: Dementia with Lewy bodies (DLB) is the second most common type of neurodegenerative dementia. Here, we report a case of dementia associated with anti-Rho-GTPase-activating protein 26 (ARHGAP26) autoantibodies, which...
4.
van de Velden D, Heide E, Bouter C, Bucerius J, Riedel C, Focke N
Clin Neurophysiol
. 2023 Oct;
156:4-13.
PMID: 37832322
Objective: To determine the effect of inverse methods and timepoints of interictal epileptic discharges (IEDs) used for high-density electric source imaging (hd-ESI) in pharmacoresistant focal epilepsies. Methods: We retrospectively evaluated...
5.
Hansen N, Teegen B, Hirschel S, Wiltfang J, Schott B, Bartels C, et al.
Front Psychiatry
. 2023 Jul;
14:1227824.
PMID: 37502813
Background: Autoantibodies against the vesicular glutamate transporter type 2 (VGlut2) can trigger impaired synaptic signaling and are described here for the first time in association with mixed dementia. Methods: We...
6.
Muller S, Khadhraoui E, Hansen N, Jamous A, Langer P, Wiltfang J, et al.
BMC Neurol
. 2023 Mar;
23(1):114.
PMID: 36944914
Background: Although Dementia with Lewy bodies (DLB) is the second most common form of dementia in elderly patients, it remains underdiagnosed compared with Alzheimer's (AD) and Parkinson's diseases (PD). This...
7.
Bouter C, Ott F, Gunther D, Weig L, Schmitz-Peiffer F, Rozyyeva M, et al.
J Neural Transm (Vienna)
. 2023 Feb;
130(8):1013-1027.
PMID: 36853560
In recent years, there has been growing evidence that cannabinoids have promising medicinal and pharmacological effects. However, the growing interest in medical cannabis highlights the need to better understand brain...
8.
Hansen N, Bouter C, Muller S, van Riesen C, Khadhraoui E, Ernst M, et al.
Brain Sci
. 2023 Feb;
13(2).
PMID: 36831785
Background: Prodromal dementia with Lewy bodies (DLB) can emerge with the onset of mild cognitive impairment (MCI). Standard biomarkers can help identify such patients to improve therapy and treatment strategies....
9.
Woyk K, Sahlmann C, Hansen N, Timaus C, Muller S, Khadhraoui E, et al.
J Neuroimaging
. 2022 Dec;
33(2):256-268.
PMID: 36465027
Background And Purpose: The diagnosis of Dementia with Lewy Bodies (DLB) is challenging due to various clinical presentations and clinical and neuropathological features that overlap with Alzheimer's disease (AD). The...
10.
Hansen N, Muller S, Khadhraoui E, Riedel C, Langer P, Wiltfang J, et al.
Front Aging Neurosci
. 2022 Oct;
14:815813.
PMID: 36274999
Background: Dementia with Lewy bodies (DLB) is a type of dementia often diagnosed in older patients. Since its initial symptoms range from delirium to psychiatric and cognitive symptoms, the diagnosis...